Eight corneas from four dogs were examined in this
investigation. All animals were treated in accordance with the ARVO
Statement for the Use of Animals in Ophthalmic and Vision Research.
Each animal was euthanatized for reasons other than use in this study
and all were free of obvious ocular disease. The eyes were enucleated
within 30 minutes of death and immersion fixed whole in 4%
paraformaldehyde-0.2% picric acid in 0.1 M phosphate buffer (pH 7.4)
for 24 to 72 hours. Each cornea, including approximately 1 to 2 mm of
the contiguous corneoscleral limbus, was dissected from surrounding
ocular tissues and stored in fresh fixative at 4°C until it was
sectioned.
Before sectioning, each cornea was cut with a razor blade into six to
eight wedge-shaped segments extending from corneal apex to limbus. Each
segment was soaked for 30 to 60 minutes in 0.1 M phosphate buffer
containing 30% sucrose, followed by an additional soaking for 5
minutes in optimal cutting temperature (OCT) compound (Miles
Laboratories, Elkhart, IN). Approximately one half of the corneal
wedges were sectioned in a cryostat in the anterior–posterior
direction (tangential to the corneal surface), and the remainder were
sectioned perpendicular to the corneal surface. Serial 30-μm-thick
sections were collected in tissue culture wells filled with chilled
phosphate-buffered saline (PBS).
Immunohistochemical labeling of corneal nerves was performed on
free-floating tissue sections by using a standardized
avidin-biotin-horseradish peroxidase procedure. Sections were incubated
overnight at 4°C in primary antisera directed against one of five
neuronal markers: PGP-9.5 (1:5000; Chemicon International, Inc.,
Temecula, CA), CGRP (1:5000; Amersham, Arlington Heights, IL), SP
(1:4000; Peninsula, Belmont, CA), tyrosine hydroxylase (TH, 1:400; Pel
Freeze Biological; Rogers, AR), and vasoactive intestinal polypeptide
(VIP; 1:500; Peninsula). Immunolabeled nerve fibers were visualized by
using a kit (Vectastain ABC Elite; Vector Laboratories, Burlingame,
CA) with diaminobenzidine (DAB) as the substrate. Specificity of the
immunocytochemical procedure was confirmed for each antiserum by
incubating randomly selected sections in normal serum without the
appropriate primary antibody.
All sections were critically examined in a light microscope (BH2;
Olympus, Lake Success, NY). The innervation density and distribution
pattern for each nerve fiber population under investigation was
documented by making a series of line drawings with a drawing tube
attached to the microscope and by photomicrographs (T-Max 100 film;
Eastman Kodak, Rochester, NY).
Computer-assisted quantitative analyses of immunostained
corneal nerve fibers were performed in two corneas from different
animals to determine the percentages of corneal PGP-9.5–immunoreactive
(IR) nerves that contained CGRP, SP, TH, and VIP. Fifty, 30-μm-thick
perpendicular sections from each cornea were collected in serial order,
and every fifth section was processed immunohistochemically for
PGP-9.5, CGRP, SP, TH, or VIP. Immunolabeled nerve fibers in four
randomly selected sections from each group were then drawn at ×50
magnification by using a drawing tube attached to the light microscope,
and the area occupied by immunolabeled nerve fibers was determined by
image analysis software (NIH Image, provided in the public domain by
the National Institutes of Health, Bethesda, MD, and available at
http://www.nih.gov/od/oba). Nerve-density analyses were conducted on
the central half of each corneal section, extending from the corneal
apex for a distance of 4.75 mm toward the limbus. The results were then
averaged for each group, and the innervation densities of corneal
CGRP-, SP-, TH-, and VIP-IR nerve fibers were calculated as percentages
of baseline PGP-9.5–IR innervation density.